Eli Lilly's lawsuit, filed in U.S. District Court in Miami, accuses DrugPlace, a Florida mail-order pharmacy, and Community Health Initiative, an organization linked to the Church of God in Christ, of orchestrating a long-term fraud scheme.
The lawsuit claims that DrugPlace purchased large quantities of Trulicity, falsely claiming they were dispensed to church members, while actually selling the medication on the secondary market. Lilly's investigation revealed suspicious patterns in rebate claims, including identical prescription quantities and a lack of typical patient behavior, raising red flags about the legitimacy of the claims.
The church, while not named as a defendant, has bishops implicated in the fraud, which has reportedly been ongoing for at least six years. Lilly is seeking legal remedies, including a temporary restraining order, to halt the alleged fraudulent activities and protect patient access to its medications.
The case underscores the potential for widespread fraud in the pharmaceutical industry, which could have broader implications for drug pricing and access if similar schemes are prevalent